Trials / Recruiting
RecruitingNCT03117946
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biological samples | blood and tumor tissue sample |
Timeline
- Start date
- 2017-05-29
- Primary completion
- 2026-08-29
- Completion
- 2026-11-29
- First posted
- 2017-04-18
- Last updated
- 2024-12-27
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03117946. Inclusion in this directory is not an endorsement.